Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Rothman

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|March 9, 2010
Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tabletsDonald L Patrick, Tom Burns, Pierluigi Morosini, et al.
BJU International|September 17, 2008
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practiceDonald L Patrick, François Giuliano, Kai Fai Ho, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001Catherine Acquadro, Rick Berzon, Dominique Dubois, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 7, 2009
Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force ReportMargaret Rothman, Laurie Burke, Pennifer Erickson, et al.
BJU International|July 24, 2008
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetineRidwan Shabsigh, Donald L Patrick, David L Rowland, et al.
Current Medical Research and Opinion|February 6, 2009
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophreniaDonald L Patrick, Tom Burns, Pierluigi Morosini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrumentLeah Kleinman, Margaret Rothman, Richard Strauss, et al.
The Journal of Sexual Medicine|November 3, 2009
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetineChris McMahon, Sae Woong Kim, Nam Cheol Park, et al.
European Urology|October 24, 2007
Premature ejaculation: results from a five-country European observational studyFrançois Giuliano, Donald L Patrick, Hartmut Porst, et al.
The Journal of Sexual Medicine|April 7, 2010
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculationStanley E Althof, Gerald B Brock, Raymond C Rosen, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|March 9, 2010
Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tabletsDonald L Patrick, Tom Burns, Pierluigi Morosini, et al.
BJU International|September 17, 2008
The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practiceDonald L Patrick, François Giuliano, Kai Fai Ho, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 25, 2003
Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001Catherine Acquadro, Rick Berzon, Dominique Dubois, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 7, 2009
Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force ReportMargaret Rothman, Laurie Burke, Pennifer Erickson, et al.
BJU International|July 24, 2008
Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetineRidwan Shabsigh, Donald L Patrick, David L Rowland, et al.
Current Medical Research and Opinion|February 6, 2009
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophreniaDonald L Patrick, Tom Burns, Pierluigi Morosini, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2006
The infant gastroesophageal reflux questionnaire revised: development and validation as an evaluative instrumentLeah Kleinman, Margaret Rothman, Richard Strauss, et al.
The Journal of Sexual Medicine|November 3, 2009
Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetineChris McMahon, Sae Woong Kim, Nam Cheol Park, et al.
European Urology|October 24, 2007
Premature ejaculation: results from a five-country European observational studyFrançois Giuliano, Donald L Patrick, Hartmut Porst, et al.
The Journal of Sexual Medicine|April 7, 2010
Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculationStanley E Althof, Gerald B Brock, Raymond C Rosen, et al.
Pageof 3